- Home
- YETI vs JANX Comparison
YETI vs JANX Comparison
Compare YETI & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YETI | JANX |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 1.8B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | YETI | JANX |
|---|---|---|
| Price | $44.82 | $13.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | $39.33 | ★ $60.27 |
| AVG Volume (30 Days) | 1.9M | ★ 2.3M |
| Earning Date | 02-12-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $1,831,326,000.00 | $10,000,000.00 |
| Revenue This Year | $4.00 | N/A |
| Revenue Next Year | $5.47 | N/A |
| P/E Ratio | $23.29 | ★ N/A |
| Revenue Growth | ★ 1.56 | N/A |
| 52 Week Low | $26.61 | $13.53 |
| 52 Week High | $46.28 | $61.59 |
Technical Indicators
Market Signals| Indicator | YETI | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 26.76 |
| Support Level | $43.82 | $13.82 |
| Resistance Level | $46.08 | $14.49 |
| Average True Range (ATR) | 1.12 | 0.49 |
| MACD | -0.26 | 0.32 |
| Stochastic Oscillator | 66.15 | 5.57 |
Price Performance
Historical ComparisonAbout YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.